Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323255620> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4323255620 endingPage "1042" @default.
- W4323255620 startingPage "1037" @default.
- W4323255620 abstract "Sacubitril/valsartan reduces all-cause mortality in heart failure (HF) patients compared to angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs). ACEIs/ARBs have been shown to decrease the incidence of atrial fibrillation (AF). We hypothesized sacubitril-valsartan decreases the incidence of AF compared to ACEis/ARBs.Clinicaltrials.gov was searched for trials by terms sacubitril/valsartan, entresto, sacubitril, valsartan. Randomized controlled human trials of sacubitril/valsartan reporting AF were included. Data were extracted independently by two reviewers. Data was pooled using a random effect model. Publication bias was evaluated by funnel plots.A total of 11 trials including 11,458 patients on sacubitril/valsartan and 10,128 patients on ACEI/ARBs were identified. A total of 284 AF events were reported in the sacubitril/valsartan group compared to 256 AF events in ACEIs/ARBs. Patients on sacubitril/valsartan were as likely as patients on ACEIs/ARBs to develop AF (pooled odds ratio [OR] = 1.091, 95% confidence interval [CI] = 0.917-1.298, p = .324). Six atrial flutter (AFl) events were reported in six trials; 48 out of 9165 patients in the sacubitril/valsartan group developed AFl compared to 46 out of 8759 in ACEi/ARBs group. There was no difference in AFl risk between the two groups (pooled OR = 1.028, 95% CI = 0.681-1.553, p = .894). Finally, sacubitril/valsartan did not reduce the risk of atrial arrhythmias (AF + AFl) compared to ACEi/ARBs (pooled OR = 1.081, 95% CI = 0.922-1.269, p = .337).Although sacubitril/valsartan reduces mortality compared to ACEIs/ARBs in HF patients, they do not reduce AF risk compared to these drugs." @default.
- W4323255620 created "2023-03-06" @default.
- W4323255620 creator A5010095254 @default.
- W4323255620 creator A5012681244 @default.
- W4323255620 creator A5037758591 @default.
- W4323255620 creator A5054895333 @default.
- W4323255620 creator A5074714597 @default.
- W4323255620 creator A5089766313 @default.
- W4323255620 date "2023-03-16" @default.
- W4323255620 modified "2023-10-02" @default.
- W4323255620 title "Effect of sacubitril–valsartan on the incidence of atrial fibrillation: A meta‐analysis" @default.
- W4323255620 cites W2113698123 @default.
- W4323255620 cites W2143094666 @default.
- W4323255620 cites W2605980487 @default.
- W4323255620 cites W2734349140 @default.
- W4323255620 cites W2891211611 @default.
- W4323255620 cites W2915125346 @default.
- W4323255620 cites W2982129752 @default.
- W4323255620 cites W3016940193 @default.
- W4323255620 cites W3111457677 @default.
- W4323255620 cites W3124689299 @default.
- W4323255620 doi "https://doi.org/10.1111/jce.15880" @default.
- W4323255620 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36871177" @default.
- W4323255620 hasPublicationYear "2023" @default.
- W4323255620 type Work @default.
- W4323255620 citedByCount "0" @default.
- W4323255620 crossrefType "journal-article" @default.
- W4323255620 hasAuthorship W4323255620A5010095254 @default.
- W4323255620 hasAuthorship W4323255620A5012681244 @default.
- W4323255620 hasAuthorship W4323255620A5037758591 @default.
- W4323255620 hasAuthorship W4323255620A5054895333 @default.
- W4323255620 hasAuthorship W4323255620A5074714597 @default.
- W4323255620 hasAuthorship W4323255620A5089766313 @default.
- W4323255620 hasConcept C126322002 @default.
- W4323255620 hasConcept C156957248 @default.
- W4323255620 hasConcept C164705383 @default.
- W4323255620 hasConcept C2775999527 @default.
- W4323255620 hasConcept C2776754050 @default.
- W4323255620 hasConcept C2777387769 @default.
- W4323255620 hasConcept C2778198053 @default.
- W4323255620 hasConcept C2779161974 @default.
- W4323255620 hasConcept C44249647 @default.
- W4323255620 hasConcept C71924100 @default.
- W4323255620 hasConcept C84393581 @default.
- W4323255620 hasConceptScore W4323255620C126322002 @default.
- W4323255620 hasConceptScore W4323255620C156957248 @default.
- W4323255620 hasConceptScore W4323255620C164705383 @default.
- W4323255620 hasConceptScore W4323255620C2775999527 @default.
- W4323255620 hasConceptScore W4323255620C2776754050 @default.
- W4323255620 hasConceptScore W4323255620C2777387769 @default.
- W4323255620 hasConceptScore W4323255620C2778198053 @default.
- W4323255620 hasConceptScore W4323255620C2779161974 @default.
- W4323255620 hasConceptScore W4323255620C44249647 @default.
- W4323255620 hasConceptScore W4323255620C71924100 @default.
- W4323255620 hasConceptScore W4323255620C84393581 @default.
- W4323255620 hasIssue "4" @default.
- W4323255620 hasLocation W43232556201 @default.
- W4323255620 hasLocation W43232556202 @default.
- W4323255620 hasOpenAccess W4323255620 @default.
- W4323255620 hasPrimaryLocation W43232556201 @default.
- W4323255620 hasRelatedWork W2582199651 @default.
- W4323255620 hasRelatedWork W2604998822 @default.
- W4323255620 hasRelatedWork W2765921484 @default.
- W4323255620 hasRelatedWork W2868803160 @default.
- W4323255620 hasRelatedWork W2972799805 @default.
- W4323255620 hasRelatedWork W2997776967 @default.
- W4323255620 hasRelatedWork W2999054836 @default.
- W4323255620 hasRelatedWork W3185488917 @default.
- W4323255620 hasRelatedWork W3209057552 @default.
- W4323255620 hasRelatedWork W4221057270 @default.
- W4323255620 hasVolume "34" @default.
- W4323255620 isParatext "false" @default.
- W4323255620 isRetracted "false" @default.
- W4323255620 workType "article" @default.